Bloomberg News

J&J Raises Forecast as Profit Climbs

April 17, 2012

Johnson & Johnson, the world’s second-biggest maker of health-care products, raised its full- year earnings forecast after quarterly profit climbed on the divestiture of an older drug and revenue from new medicines. Sheila Dharmarajan reports on Bloomberg Television's "InBusiness With Margaret Brennan." (Source: Bloomberg)

Running Time: 01:25

Race, Class, and the Future of Ferguson

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus